Physician profile

Daniel G Kloda

Vascular & Interventional Radiology · Portland, ME

NPI 1558432674

$1,300.14

in general payments reported to CMS, 2019-2025

5 companies · none reported in 2025

See the full distribution for Vascular & Interventional Radiology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$202.72

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $600.82 2019-2021
Sirtex Medical INC $394.22 2019-2022
Imperative Care, INC $195.88 2023-2024 Tracstar Large Distal Platform, Zoom Rdl Radial Access System, 103cm, Zoom 88-T Large Distal Platform
Guerbet LLC $102.38 2022
Penumbra, INC. $6.84 2023 Indigo System

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Daniel G Kloda

$1,300.14

in general payments reported 2019-2025

Years
2019-2024
Top company
Boston Scientific Corporation

https://glasscript.com/doctor/549830/daniel-g-kloda

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.